Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancersJennifer Cantley, Robert L. Yauch|Nature Communications|2022Cited by 125
Rational design of potent small-molecule SMARCA2/A4 degraders acting via the recruitment of FBXO22Elisia Villemure, Robert L. Yauch|Nature Communications|2025Cited by 11
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancersRobert L. Yauch, Michael Berlin|Research Square|2022Cited by 2